BioCentury | Dec 10, 2020
Finance

Dec. 9 Quick Takes: Nuance leads bolus of venture rounds for China’s innovators; plus launches for Hillhouse’s Overland, OSI’s PepGen and Atlas’ Vigil and more

...AI to classify and sort cells. TARGETSTREM2 - Triggering receptor expressed on myeloid cells 2 BC Staff Nuance Biotech Hillhouse...
BioCentury | Dec 21, 2018
Product Development

China’s clinical talent gap

...to global standards set by the International Council for Harmonisation. And CEO Mark Lotter said Nuance Biotech (Shanghai) Co. Ltd....
...supplementing their teams with junior-level personnel from Western companies or multinationals. CEO Mark Lotter said Nuance Biotech (Shanghai) Co. Ltd....
...Brunswick, N.J. MabSpace Biosciences Co. Ltd., Suzhou, China National Medical Products Administration (NMPA), Beijing, China Nuance Biotech (Shanghai) Co. Ltd....
BioCentury | Jun 29, 2018
Financial News

C-Bridge leads Nuance's series B

...in Greater China and South Africa. Nuance lists both compounds in its pipeline (see "Celleron, Nuance Biotech...
...an oral topoisomerase I inhibitor. C-Bridge's Neo Zhang joined Nuance's board. Nuance Biotech (Shanghai) Co. Ltd., Shanghai, China Sandi Wong C-Bridge Capital Nuance Biotech...
BioCentury | Jun 28, 2018
Financial News

C-Bridge leads Nuance's series B

...inhibitor. CXD201 is an oral topoisomerase I inhibitor. C-Bridge's Neo Zhang joined Nuance's board. Sandi Wong C-Bridge Capital Nuance Biotech...
BioCentury | Jun 26, 2018
Company News

Nuance gains Chinese rights to Pacira's Exparel

...Pacira Pharmaceuticals Inc. (NASDAQ:PCRX) granted Nuance Biotech Co. Ltd. (Shanghai, China) exclusive rights to develop and commercialize...
...Pharmaceuticals Inc. (NASDAQ:PCRX), Parsippany, N. J. Nuance Biotech Co. Ltd., Shanghai, China Business: Neurology Jennie Walters Exparel, bupivacaine (depobupivacaine) Nuance Biotech...
BioCentury | Jan 11, 2016
Company News

Celleron, Nuance Biotech deal

...sales milestones. The companies did not respond to inquiries. Celleron Therapeutics Ltd. , Abingdon, U.K. Nuance Biotech...
BioCentury | Jan 8, 2016
Company News

Nuance gains territorial rights to Celleron candidates

...Celleron Therapeutics Ltd. (Abingdon, U.K.) granted Nuance Biotech Inc. (Shanghai, China) an exclusive option for development and...
BioCentury | Apr 20, 2015
Emerging Company Profile

East by South

...round this quarter. Companies and Institutions Mentioned Aspen Pharmacare Holdings Ltd. (JSE:APN), Durban, South Africa Nuance Biotech...
...N.C. SciClone Pharmaceuticals Inc. (NASDAQ:SCLN), Foster City, Calif. University of Pretoria, Hatfield, South Africa Sidebars Nuance Biotech...
Items per page:
1 - 8 of 8
BioCentury | Dec 10, 2020
Finance

Dec. 9 Quick Takes: Nuance leads bolus of venture rounds for China’s innovators; plus launches for Hillhouse’s Overland, OSI’s PepGen and Atlas’ Vigil and more

...AI to classify and sort cells. TARGETSTREM2 - Triggering receptor expressed on myeloid cells 2 BC Staff Nuance Biotech Hillhouse...
BioCentury | Dec 21, 2018
Product Development

China’s clinical talent gap

...to global standards set by the International Council for Harmonisation. And CEO Mark Lotter said Nuance Biotech (Shanghai) Co. Ltd....
...supplementing their teams with junior-level personnel from Western companies or multinationals. CEO Mark Lotter said Nuance Biotech (Shanghai) Co. Ltd....
...Brunswick, N.J. MabSpace Biosciences Co. Ltd., Suzhou, China National Medical Products Administration (NMPA), Beijing, China Nuance Biotech (Shanghai) Co. Ltd....
BioCentury | Jun 29, 2018
Financial News

C-Bridge leads Nuance's series B

...in Greater China and South Africa. Nuance lists both compounds in its pipeline (see "Celleron, Nuance Biotech...
...an oral topoisomerase I inhibitor. C-Bridge's Neo Zhang joined Nuance's board. Nuance Biotech (Shanghai) Co. Ltd., Shanghai, China Sandi Wong C-Bridge Capital Nuance Biotech...
BioCentury | Jun 28, 2018
Financial News

C-Bridge leads Nuance's series B

...inhibitor. CXD201 is an oral topoisomerase I inhibitor. C-Bridge's Neo Zhang joined Nuance's board. Sandi Wong C-Bridge Capital Nuance Biotech...
BioCentury | Jun 26, 2018
Company News

Nuance gains Chinese rights to Pacira's Exparel

...Pacira Pharmaceuticals Inc. (NASDAQ:PCRX) granted Nuance Biotech Co. Ltd. (Shanghai, China) exclusive rights to develop and commercialize...
...Pharmaceuticals Inc. (NASDAQ:PCRX), Parsippany, N. J. Nuance Biotech Co. Ltd., Shanghai, China Business: Neurology Jennie Walters Exparel, bupivacaine (depobupivacaine) Nuance Biotech...
BioCentury | Jan 11, 2016
Company News

Celleron, Nuance Biotech deal

...sales milestones. The companies did not respond to inquiries. Celleron Therapeutics Ltd. , Abingdon, U.K. Nuance Biotech...
BioCentury | Jan 8, 2016
Company News

Nuance gains territorial rights to Celleron candidates

...Celleron Therapeutics Ltd. (Abingdon, U.K.) granted Nuance Biotech Inc. (Shanghai, China) an exclusive option for development and...
BioCentury | Apr 20, 2015
Emerging Company Profile

East by South

...round this quarter. Companies and Institutions Mentioned Aspen Pharmacare Holdings Ltd. (JSE:APN), Durban, South Africa Nuance Biotech...
...N.C. SciClone Pharmaceuticals Inc. (NASDAQ:SCLN), Foster City, Calif. University of Pretoria, Hatfield, South Africa Sidebars Nuance Biotech...
Items per page:
1 - 8 of 8